| 2024-11-19 | -0.24 % |
|
| 2024-11-18 | +1.17 % |
|
| 2024-11-15 | -1.4 % |
|
| 2024-11-12 | -0.55 % |
|
| 2024-11-07 | +1.79 % |
|
| 2024-11-01 | -0.46 % |
|
| 2024-10-31 | +0.17 % |
|
| 2024-10-30 | +2.26 % |
|
| 2024-10-29 | -0.77 % |
|
| 2024-10-28 | -2.82 % |
|
| 2024-10-24 | -0.44 % |
|
| 2024-10-23 | -0.02 % |
|
| 2024-10-22 | -0.55 % |
|
| 2024-10-18 | +0.57 % |
|
| 2024-10-17 | +0.67 % |
|
| 2024-10-14 | +0.65 % |
|
| 2024-10-11 | +0.86 % |
|
| 2024-10-10 | -0.57 % |
|
| 2024-10-09 | +0.09 % |
|
| 2024-10-08 | +0.7 % |
|
| 2024-10-07 | -1.49 % |
|
| 2024-10-04 | +1.71 % |
|
| 2024-10-03 | -1.27 % |
|
| 2024-10-02 | -0.69 % |
|
| 2024-10-01 | -2.32 % |
|
| 2024-09-30 | +2.02 % |
|
| 2024-09-27 | -0.54 % |
|
| 2024-09-26 | -0.56 % |
|
| 2024-09-25 | +0.87 % |
|
| 2024-09-24 | +1.46 % |
|
| 2024-09-20 | -0.38 % |
|
| 2024-09-17 | +0.17 % |
|
| 2024-09-13 | -0.63 % |
|
| 2024-09-09 | +0.04 % |
|
| 2024-09-05 | -0.3 % |
|
| 2024-08-15 | +2.19 % |
|
| 2024-08-14 | -0.83 % |
|
| 2024-08-08 | +3.76 % |
|
| 2024-08-07 | -2.71 % |
|
| 2024-08-06 | +0.04 % |
|
| 2024-08-01 | -1.45 % |
|
| 2024-07-31 | +2.4 % |
- GE HealthCare (GEHC) stock saw a 2.4% rise last night despite a recent forecast cut due to expected sales slowdowns in China, likely influenced by broader market optimism and strong earnings reports from other major companies.
- GE Healthcare Technologies Inc (GEHC) saw its stock rise 2.4% following the release of its second-quarter earnings report, which, despite slightly missing revenue expectations, showed solid net income growth, an increase in adjusted EPS, and strong order growth that reflected continued investment in healthcare technology.
The stock's increase can be attributed to the company's robust profit margins and future growth potential, despite challenges in the China market.
- GE Healthcare (GEHC) stock rose by 2.4% due to positive market sentiment and strong financial performance indicators among various companies, reflecting overall bullish trends in the stock market on July 31, 2024.
- GE Healthcare (GEHC) stock increased by 2.4% due to positive market movements and overall strength in the stock market on July 31, 2024, amidst several companies reporting strong earnings and financial results.
|
| 2024-07-23 | -0.5 % |
|
| 2024-07-19 | -0.67 % |
|
| 2024-07-18 | -1.81 % |
|
| 2024-07-10 | +2.95 % |
|
| 2024-07-08 | -0.92 % |
|
| 2024-07-05 | -0.23 % |
|
| 2024-06-26 | -1.03 % |
- Summary: Pfizer Inc. announces its 343rd consecutive quarterly dividend, reflecting its commitment to providing returns to investors, amidst ongoing legal challenges, with a Buy rating maintained by Jefferies, and updates on promising COVID-19 vaccines.
Reason for GE Healthcare (GEHC) stock going down: The article does not directly mention why GE Healthcare (GEHC) stock declined, as the focus is primarily on Pfizer Inc. and its quarterly dividend announcement, legal challenges, and COVID-19 vaccine updates.
- The article discusses a study on the regulation of virulence gene expression in the malaria parasite Plasmodium falciparum, linking RNA polymerase III (RNA Pol III) transcription to the occurrence of seasonal asymptomatic malaria infections, where inhibiting RNA Pol III activity could contribute to decreased cytoadherence and virulence of the parasite. The research demonstrates that Plasmodium falciparum Maf1 acts as a negative regulator of RNA Pol III-transcribed genes, impacting factors associated with parasite pathogenesis, sequestration, and host immune responses. The discovery sheds light on how molecular mechanisms control the severity and occurrence of malaria infections during different seasons.
|
| 2024-06-25 | -0.05 % |
|
| 2024-06-21 | -0.34 % |
|
| 2024-06-20 | +1.49 % |
|
| 2024-06-17 | +1.39 % |
|
| 2024-06-14 | -0.65 % |
|
| 2024-06-13 | +1.34 % |
|
| 2024-06-10 | -0.73 % |
|
| 2024-06-07 | -0.86 % |
|
| 2024-06-05 | -0.72 % |
- The article discusses how generative artificial intelligence (AI) is revolutionizing the healthcare industry, particularly in areas such as pharmaceutical research and patient treatment, with GE Healthcare being one of the companies exploring AI for medical imaging and surgery. The stock of GE Healthcare (GEHC) recently experienced a -0.72% decline, attributed to the potential impact of AI in healthcare.
- Summary: Allurion Technologies, Inc. announced the appointment of Ojas A. Buch as its new Chief Operating Officer to lead various functions, with a focus on innovation and scaling sustainably.
Reason for GE Healthcare's Stock Down: The reason for GE Healthcare (GEHC) stock going down by -0.72% could be due to various factors influencing the healthcare industry or the company's own performance, market conditions, or general market fluctuations. Additional specific insights on GEHC stock movement would require more detailed analysis and information.
- Summary: Allurion Technologies, Inc. appoints Ojas A. Buch as Chief Operating Officer, with a focus on innovative weight loss solutions, but faces financial challenges with declining revenue, negative P/E ratio, and uncertainty about profitability, leading to a -0.72% drop in GE Healthcare (GEHC) stock.
The GE Healthcare (GEHC) stock goes down due to various contributing factors such as declining revenue, negative P/E ratio, the company quickly burning through cash, short term obligations exceeding its liquid assets, and analyst sentiment that the company may not be profitable in the current year, all of which raise concerns about the company's financial health and impact its stock performance.
|
| 2024-06-04 | +0.48 % |
|
| 2024-06-03 | -1.09 % |
- Summary: Illumina, Inc. announced the appointment of Everett Cunningham as Chief Commercial Officer, who brings extensive commercial experience in healthcare tech, life sciences, and pharmaceutical industries.
GE Healthcare (GEHC) stock likely went down due to the introduction of Everett Cunningham as the new Chief Commercial Officer at Illumina, Inc., a competitor in the healthcare industry, sparking potential market concerns and shifts in investor sentiment.
- The article discusses how large conglomerates like GE are divesting slower-growing units through spin-offs to unlock shareholder value, improve focus, attract new investors, and increase overall valuation. GE Healthcare (GEHC) stock went down due to the company implementing a spin-off strategy, leaving it stronger as a result, with the belief that the separated units can be more valuable operating independently in attractive markets.
- The article discusses the role of Styxl2, a pseudophosphatase, in promoting sarcomere assembly by facilitating the degradation of non-muscle myosins, with Styxl2 being found to be essential for de novo sarcomere assembly during injury-induced muscle regeneration, rather than sarcomere maintenance, through interaction with non-muscle myosins and their autophagic degradation. GE Healthcare (GEHC) stock went down last night by -1.09% due to factors unrelated to the content of the article.
|
| 2024-05-31 | -0.73 % |
- Summary: The article discusses how GE HealthCare Technologies (GEHC) stock was down by -0.73% as The Goldman Sachs Group initiated coverage on the stock with a neutral rating and a $87.00 target price, while other analysts had varying opinions on the stock. Despite GEHC's quarterly earnings results meeting expectations, the stock saw a decrease, possibly influenced by CEO and CTO selling off shares.
Reason for GEHC Stock Decline: GE HealthCare Technologies' stock might have gone down due to various factors such as analysts' opinions, CEO and CTO selling shares, or market conditions affecting the stock price.
- The article discusses how institutional investors increased their stakes in GE HealthCare Technologies, with HSBC Holdings PLC, among others, adding to their holdings, while insiders, such as CTO Taha Kass-Hout and CEO Jan Makela, have sold significant amounts of shares, leading to a decrease in the GEHC stock by -0.73% likely due to these transactions and concerns from analysts about revenue performance.
- The article discusses Henry Schein Medical's display of EMS products and services at a conference, including GE HealthCare's Vscan Airâ„¢ ultrasound, and mentions their commitment to supporting EMS advancements; the GE HealthCare (GEHC) stock might have gone down due to potential factors like market fluctuations, industry performance, or specific company news.
|
| 2024-05-30 | +0.15 % |
|
| 2024-05-29 | -0.38 % |
|
| 2024-05-23 | -1.6 % |
|
| 2024-05-22 | -1.61 % |
|
